Related Experiment Video
Updated: Apr 8, 2026

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
11.2K
A temporal correlation function for the association between patient-reported outcome and clinical endpoints.
1Gilead Sciences Inc., Foster City, CA, USA.
Pharmaceutical Statistics
|June 24, 2015
Summary
This study introduces a new method to measure the association between clinical trial endpoints over time. The approach helps visualize and analyze correlations, aiding research and hypothesis generation.
Area of Science:
- Biostatistics
- Clinical Trial Methodology
- Health Outcomes Research
Background:
- Clinical trials often involve multiple endpoints, necessitating methods to understand their interrelationships.
- Quantifying the association between different types of endpoints, such as patient-reported outcomes and clinical measures, presents a challenge.
Purpose of the Study:
- To propose and validate a novel multiple event approach for profiling temporal correlations between two clinical trial endpoints.
- To provide a tool for visualizing and inferring associations, extending existing recurrent event methodologies.
Main Methods:
- Developed a multiple event approach incorporating a temporal correlation function.
- Utilized a correlation function plot with confidence bands for visualization.
- Extended methodologies from recurrent event data analysis.
Main Results:
- The proposed approach is generally unbiased.
- Demonstrated utility through application to a real clinical trial dataset.
- The method effectively profiles temporal associations between endpoints.
Conclusions:
- The multiple event approach offers a valuable tool for analyzing associations between clinical trial endpoints.
- Applicable to patient-reported outcomes, adverse events, and any two time-to-event endpoints.
- Facilitates data visualization and inference in clinical trial research.
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
384
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
384
Drug Concentration Versus Time Correlation
2.9K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
2.9K
Receiver Operating Characteristic Plot
579
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
579
Comparing the Survival Analysis of Two or More Groups
715
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
715
Introduction To Survival Analysis
975
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
975
Actuarial Approach
375
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
375

